Improving the early detection of birth defects and potential complications can enhance decision-making and treatment options, supporting improved care for at-risk newborns and their mothers. The EPIQ Elite for Obstetrics & Gynecology combines with innovative transducers and software to offer an integrated solution that enhances fetal assessment and meets the specific needs of obstetrics patients during the early stages of pregnancy.
The ergonomic, lightweight V9-2 transducer is the first high-frequency PureWave transducer focused on getting fine detailed images as early as possible to help clinicians easily perform confident assessments of fetal health. Paired with TrueVue, the EPIQ Elite system allows clinicians to manipulate a virtual light source around the 3D images of the fetus, producing images that are both incredibly lifelike and that provide a high level of detail to enable the identification of any abnormalities early on in pregnancy. The Philips aBiometry Assist application uses anatomical intelligence to automate time spent gathering measurements, reducing exam time to allow clinicians to spend more time with mothers-to-be.
“The high-resolution images I’m able to acquire using the V9-2 and eL18-4 PureWave transducers give me the ability to quickly evaluate a baby’s early development. With exceptional 2D and 3D resolution and excellent depth penetration, I can make more confident fetal health assessments during each trimester,” said Luis F. Goncalves, MD from Phoenix Children’s Hospital.
The EPIQ Elite for Obstetrics & Gynecology will be showcased at the upcoming Society of Maternal-Fetal Medicine (SMFM) conference (Las Vegas, Nevada, February 13-15). The EPIQ Elite for General Imaging, including the Ultimate Ultrasound Solution for Vascular Assessment, will be showcased at the European Congress of Radiology (ECR) (Vienna, Austria February 28 – March 3). More information about the EPIQ Elite ultrasound system is available here.
 Belch JJ, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003 28;163(8):884-92.
 Report: EPIQ Ultrasound Marketing Claims Evaluation Study, September 10, 2018, Philips.